{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:49:29Z","timestamp":1767422969582},"reference-count":47,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The acquisition of immunity following subclinical or resolved infection with the intracellular parasite<jats:italic>Leishmania donovani<\/jats:italic>suggests that vaccination could prevent visceral leishmaniasis (VL). The LACK (<jats:italic>Leishmania<\/jats:italic>homolog of receptors for activated C kinase) antigen is of interest as a vaccine candidate for the leishmaniases because of its immunopathogenic role in murine<jats:italic>L. major<\/jats:italic>infection. Immunization of mice with a truncated (24-kDa) version of the 36-kDa LACK antigen, delivered in either protein or DNA form, was found previously to protect against cutaneous<jats:italic>L. major<\/jats:italic>infection by redirecting the early T-cell response away from a pathogenic interleukin-4 (IL-4) response and toward a protective Th1 response. The amino acid sequence of the<jats:italic>Leishmania<\/jats:italic>p36(LACK) antigen is highly conserved, but the efficacy of this vaccine antigen in preventing disease caused by strains other than<jats:italic>L. major<\/jats:italic>has not been determined. We investigated the efficacy of a p36(LACK) DNA vaccine against VL because of the serious nature of this form of leishmaniasis and because it was unclear whether the LACK vaccine would be effective in a model where there was not a dominant pathogenic IL-4 response. We demonstrate here that although the LACK DNA vaccine induced a robust parasite-specific Th1 immune response (IFN-\u03b3 but not IL-4 production) and primed for an in vivo T-cell response to inoculated parasites, it did not induce protection against cutaneous or systemic<jats:italic>L. donovani<\/jats:italic>challenge. Coadministration of IL-12 DNA with the vaccine did not enhance the strong vaccine-induced Th1 response or augment a protective effect.<\/jats:p>","DOI":"10.1128\/iai.69.8.4719-4725.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:58:18Z","timestamp":1027763898000},"page":"4719-4725","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":130,"title":["<i>Leishmania donovani<\/i>p36(LACK) DNA Vaccine Is Highly Immunogenic but Not Protective against Experimental Visceral Leishmaniasis"],"prefix":"10.1128","volume":"69","author":[{"given":"Peter C.","family":"Melby","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Medical Service, Department of Veterans Affairs Medical Center, South Texas Veterans Health Care System,1 and"},{"name":"<!--label omitted: 2-->Departments of Medicine2 and"},{"name":"<!--label omitted: 3-->Microbiology,3 University of Texas Health Science Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Yang","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Medical Service, Department of Veterans Affairs Medical Center, South Texas Veterans Health Care System,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Zhao","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Medical Service, Department of Veterans Affairs Medical Center, South Texas Veterans Health Care System,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"Perez","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Medical Service, Department of Veterans Affairs Medical Center, South Texas Veterans Health Care System,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Cheng","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Medical Service, Department of Veterans Affairs Medical Center, South Texas Veterans Health Care System,1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7904381"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(05)80360-2"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/154.6.1003"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113969"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.33.2.498-500.1981"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.12.3272-3279.1988"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.24.11473"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<762::AID-IMMU762>3.0.CO;2-4"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00207-3"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300628"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.1.245-251.2001"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/4000"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1137"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.11.4261-4267.1995"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.144.2.699","article-title":"Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis","volume":"144","author":"Jaffe C. L.","year":"1990","unstructured":"Jaffe C. L. Rachamim N. Sarfstein R. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.J. Immunol.1441990699706","journal-title":"J. Immunol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.2.645"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.7.3641-3644.1999"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5286.421"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1\u20137 and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye P. M.","year":"1991","unstructured":"Kaye P. M. Curry A. J. Blackwell J. M. Differential production of Th1\u20137 and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.J. Immunol.146199127632770","journal-title":"J. Immunol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80342-8"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.4049\/jimmunol.158.7.3317","article-title":"Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness","volume":"158","author":"Launois P.","year":"1997","unstructured":"Launois P. Swihart K. G. Milon G. Louis J. A. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness.J. Immunol.158199733173324","journal-title":"J. Immunol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/107999000312748"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0197-35"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.10.5595-5602.2000"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.1.18-27.1998"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7725103"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4049\/jimmunol.129.1.344","article-title":"Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity","volume":"129","author":"Murray H. W.","year":"1982","unstructured":"Murray H. W. Masur H. Keithly J. S. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.J. Immunol.1291982344350","journal-title":"J. Immunol."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.4049\/jimmunol.163.3.1467","article-title":"Protective immune responses induced by vaccination with an expression genomic library of Leishmania major.","volume":"163","author":"Piedrafita D.","year":"1999","unstructured":"Piedrafita D. Xu D. Hunter D. Harrison R. A. Liew F. Y. Protective immune responses induced by vaccination with an expression genomic library of Leishmania major. J. Immunol. 163 1999 1467 1472","journal-title":"J. Immunol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.7.1111"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.4049\/jimmunol.156.11.4318","article-title":"Presentation of the protective parasite antigen LACK by Leishmania- infected macrophages","volume":"156","author":"Prina E.","year":"1996","unstructured":"Prina E. Lang T. Glaichenhaus N. Antoine J. C. Presentation of the protective parasite antigen LACK by Leishmania- infected macrophages.J. Immunol.156199643184327","journal-title":"J. Immunol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.4049\/jimmunol.150.6.2322","article-title":"Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis","volume":"150","author":"Rachamim N.","year":"1993","unstructured":"Rachamim N. Jaffe C. L. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.J. Immunol.150199323222331","journal-title":"J. Immunol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01160.x"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.4049\/jimmunol.160.2.884","article-title":"Control of Leishmania major by a monoclonal alpha beta T cell repertoire","volume":"160","author":"Reiner S. L.","year":"1998","unstructured":"Reiner S. L. Fowell D. J. Moskowitz N. H. Swier K. Brown D. R. Brown C. R. Turck C. W. Scott P. A. Killeen N. Locksley R. M. Control of Leishmania major by a monoclonal alpha beta T cell repertoire.J. Immunol.1601998884889","journal-title":"J. Immunol."},{"key":"e_1_3_2_35_2","unstructured":"Sacks D. Melby P. Animal models for the analysis of immune responses to leishmaniasis Current protocols in immunology. Coligan J. Kruisbeek A. Margulies D. Shevach E. Strober W. 1998 19.2.1 19.2.20 John Wiley & Sons Inc. New York N.Y"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00058-4"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4894-4899.1995"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4049\/jimmunol.144.3.1075","article-title":"Protection against Leishmania major in BALB\/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes","volume":"144","author":"Scott P.","year":"1990","unstructured":"Scott P. Caspar P. Sher A. Protection against Leishmania major in BALB\/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.J. Immunol.144199010751079","journal-title":"J. Immunol."},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.4049\/jimmunol.162.5.2912","article-title":"IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge","volume":"162","author":"Sin J. I.","year":"1999","unstructured":"Sin J. I. Kim J. J. Arnold R. L. Shroff K. E. McCallus D. Pachuk C. McElhiney S. P. Wolf M. W. Pompa-de Bruin S. J. Higgins T. J. Ciccarelli R. B. Weiner D. B. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.J. Immunol.162199929122921","journal-title":"J. Immunol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00075-9"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.160.8.3949","article-title":"Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis","volume":"160","author":"Sjolander A.","year":"1998","unstructured":"Sjolander A. Baldwin T. M. Curtis J. M. Handman E. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis.J. Immunol.160199839493957","journal-title":"J. Immunol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00340-0"},{"key":"e_1_3_2_43_2","first-page":"33","article-title":"Studies in the epidemiology of East African leishmaniasis. 5. Leishmania adleri and natural immunity","volume":"70","author":"Southgate B. A.","year":"1967","unstructured":"Southgate B. A. Studies in the epidemiology of East African leishmaniasis. 5. Leishmania adleri and natural immunity.J. Trop. Med. Hyg.7019673336","journal-title":"J. Trop. Med. Hyg."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.7064"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.4049\/jimmunol.140.11.3971","article-title":"Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis","volume":"140","author":"Stern J. J.","year":"1988","unstructured":"Stern J. J. Oca M. J. Rubin B. Y. Anderson S. L. Murray H. W. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.J. Immunol.140198839713977","journal-title":"J. Immunol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3279-3289.1998"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.5.2062-2069.1995"},{"key":"e_1_3_2_48_2","first-page":"173","article-title":"Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major.","volume":"84","author":"Xu D.","year":"1995","unstructured":"Xu D. Liew F. Y. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 84 1995 173 176","journal-title":"Immunology"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.8.4719-4725.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.8.4719-4725.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:05:40Z","timestamp":1682262340000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.8.4719-4725.2001"}},"subtitle":[],"editor":[{"given":"E. I.","family":"Tuomanen","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1128\/IAI.69.8.4719-4725.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.8.4719-4725.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"2001-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-05-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}